{Reference Type}: Case Reports
{Title}: Bridging therapy after recent stent implantation: case report and review of data.
{Author}: Wessler JD;Saldana F;Giugliano RP;
{Journal}: Cardiovasc Revasc Med
{Volume}: 13
{Issue}: 1
{Year}: Jan-Feb 2012
暂无{DOI}: 10.1016/j.carrev.2011.08.004
{Abstract}: For patients requiring surgery within their first year following coronary stent placement, maximizing the prevention of stent thrombosis with antiplatelet therapy while minimizing the risk of intraoperative bleeding has become a management challenge for cardiologists, surgeons and anesthesiologists. In this manuscript, we describe a case of a patient who received three stents (two of which were drug-eluting) and 7 months later was bridged with intravenous eptifibatide, a short-acting glycoprotein (GP) IIb/IIIa inhibitor, for 3 days prior to bronchoscopy and cervical mediastinoscopy for a suspected lung cancer. We then review the current literature for data and guidelines describing the use of short-acting GP IIb/IIIa as bridge therapy. Finally, we provide recommendations, based on our experience combined with this review, for bridge therapy in the perioperative period for patients with recent coronary stents.